Planned system outage: A number of IT systems will be temporarily unavailable on 7 March 2026 from 10am–6pm AEDT due to scheduled maintenance. 

Full details

Planned library system outage: Access to library e-resources - including all e-books and e-journals - will be impacted by a system upgrade on Wednesday, 18 February 2026 from 8AM - 12PM AEDT / 10AM - 2PM NZDT.

Further information

The college will be closed from 2pm (AEDT) on Wednesday 24 December 2025 until Monday 5 January 2026. We wish you a happy and safe festive period.

MyPortfolio is now available via https://myportfolio.anzca.edu.au/. Please contact the ANZCA Training team at [email protected] if you have any queries or require assistance.

Immune-to-brain signalling in CRPS: unravelling the detrimental relationship between inflammation and autonomic dysfunction.

Project Grant

The project sought to shed light on the complex interactions between the immune system and nervous system in the painful body region in people with Complex Regional Pain Syndrome (CRPS), as well as changes in pain processing pathways in CRPS. 

The three specific questions that were addressed:

  1. Which immune cells directly interact with nerves and contribute to pain in CRPS
  2. How brain activity patterns in CRPS patients compare to that of healthy individuals in response to heat pain
  3. Whether specific immune markers in the blood and skin are related to the changes in brain activity observed in CRPS patients.  

This research was intended to provide insights into the immune cell-nerve signalling pathways involved in the condition and better understand the neurological changes occurring in CRPS. The research was also intended to improve understanding of the causes of CRPS and ultimately improve diagnosis and treatment for affected individuals. 

Hunter Pain Specialists, University of Newcastle and University of Sydney NSW
Associate Professor Marc Russo

Brain and Mind Centre, University of Sydney, NSW
Associate Professor Paul Austin and Professor Luke Henderson

Murdoch University, WA
Professor Peter Drummond and Adjunct Professor Philip Finch

Sunshine Coast Clinical Research, QLD
Dr Peter Georgius

Westmead Institute for Medical Research, University of Sydney NSW
Professor Andrew Harman

The project was awarded $A70,000 through the ANZCA research grants program for 2022.   

Using the latest tissue imaging technology, the team performed the largest and most comprehensive analysis of immune cell and nerve interactions in skin biopsies from CRPS patients. Although the initial hypothesis of reduced nerve density was not supported, and no immune cell populations were increased in abundance, the study found that specific immune cells were indeed closer to nerves in CRPS-affected skin, which may contribute to persistent pain.

The study was also the first to perform ultrahigh resolution magnetic resonance imaging in patients with CRPS, enabling the most detailed analysis of brain activation changes associated with the condition. The findings revealed altered activation patterns in brain regions associated with pain, blood flow, temperature and sweating responses, when a painful stimulus was applied to the affected body region. Consistent with the original hypothesis, the study demonstrated for the first time increased hypothalamic activity in patients with CRPS, suggesting a critical role for the hypothalamus in pain and the associated blood flow, temperature, and sweating abnormalities in the affected body region. These findings helped to understand the specific contributions of nerve-immune interactions and brain changes that contribute to CRPS symptoms, shedding light on potential targets for future treatments.

The study has advanced basic scientific knowledge of the complex interplay between immune cells and nerves in the skin of CRPS patients. There has been two different immune cells populations identified, Langerhans cells and CXCR3+ lymphocyte cells, that are in closer proximity to nerves fibres relative to healthy participants. Moreover, as these closer interactions only occur in the CRPS affected body region and not an unaffected region from the same patient, we believe they contribute to ongoing pain in the condition.

It has also identified fundamental alterations in how heat pain is processed by those with CRPS. Using ultrahigh resolution brain imaging analyses, it was identified that the sensory cortex, thalamus and hypothalamus respond differently to heat pain in patients with CRPS. These brain regions are responsible for pain and autonomic responses for example, blood flow, sweating and temperature regulation, which are all disrupted in the CRPS affected body region. This suggests that these brain changes are in fact responsible for propagating ongoing pain and autonomic symptoms in CRPS patients.

Changes in clinical practice by healthcare professionals treating CRPS patients may arise from insights provided by this research. Understanding the pathogenic immune cell-nerve interactions involved in CRPS could lead to the development of targeted anti-inflammatory treatment strategies aimed at alleviating pain and improving patient outcomes. Moreover, appreciating that pain pathway changes are occurring in specific brain regions could help to develop therapies such as transcranial magnetic stimulation to alter their aberrant activity. Finally, identification of predictive immune biomarkers of CRPS could enhance pain specialists’ ability to diagnosis CRPS at an earlier timepoint and treat the condition before the brain changes become long standing. 

The grant has supported seven conference presentations: five at the Australian Pain Society meetings (2023 and 2024; four talks and one poster), a poster at the Australian Neuroscience Society, and an invited talk at IASP CRPS Special Interest Group in Bath, UK in August 2024. The project is expected to form the basis of at least three to four high-impact research articles.

Last modified: